Related Experiment Video
Updated: Dec 29, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress
Naomi X Y Ling1, Adrian Kaczmarek2, Ashfaqul Hoque1
1Metabolic Signalling Laboratory, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Abstract:
Central to cellular metabolism and cell proliferation are highly conserved signalling pathways controlled by mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK)1,2, dysregulation of which are implicated in pathogenesis of major human diseases such as cancer and type 2 diabetes. AMPK pathways leading to reduced cell proliferation are well established and, in part, act through inhibition of TOR complex-1 (TORC1) activity. Here we demonstrate reciprocal regulation, specifically that TORC1 directly down-regulates AMPK signalling by phosphorylating the evolutionarily conserved residue Ser367 in the fission yeast AMPK catalytic subunit Ssp2, and AMPK α1Ser347/α2Ser345 in the mammalian homologs, which is associated with reduced phosphorylation of activation loop Thr172. Genetic or pharmacological inhibition of TORC1 signalling led to AMPK activation in the absence of increased AMP:ATP ratios; under nutrient stress conditions this was associated with growth limitation in both yeast and human cell cultures. Our findings reveal fundamental, bi-directional regulation between two major metabolic signalling networks and uncover new opportunity for cancer treatment strategies aimed at suppressing cell proliferation in the nutrient-poor tumor microenvironment.
Insights
Mammalian target of rapamycin (mTOR) complex 1 (TORC1) directly inhibits AMP-activated protein kinase (AMPK) signaling. This reciprocal regulation impacts cell proliferation and offers new cancer treatment strategies targeting nutrient-poor tumors.
Area of Science:
- Cellular Metabolism
- Molecular Biology
- Signal Transduction
Background:
- Mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) pathways are crucial for cellular metabolism and proliferation.
- Dysregulation of these pathways is linked to diseases like cancer and type 2 diabetes.
- AMPK signaling typically reduces cell proliferation, partly by inhibiting TOR complex-1 (TORC1).
Purpose of the Study:
- To investigate the regulatory relationship between TORC1 and AMPK signaling.
- To identify the molecular mechanisms underlying this interaction.
- To explore therapeutic opportunities based on this bidirectional regulation.
Main Methods:
- Investigated TORC1's effect on AMPK signaling in yeast and mammalian cells.
- Utilized genetic and pharmacological inhibition of TORC1.
- Analyzed phosphorylation sites, including Ser367 in yeast and Ser347/345 in mammalian AMPK, and Thr172 in the activation loop.
Main Results:
- Demonstrated that TORC1 directly down-regulates AMPK signaling via phosphorylation of conserved residues.
- Observed reduced AMPK activation loop phosphorylation (Thr172) upon TORC1 inhibition.
- Showed TORC1 inhibition activates AMPK independently of AMP:ATP ratios, leading to growth limitation under nutrient stress.
Conclusions:
- Revealed a fundamental, bidirectional regulatory mechanism between mTOR and AMPK signaling networks.
- Identified a novel pathway for TORC1 to control AMPK activity.
- Uncovered potential therapeutic strategies targeting the tumor microenvironment by modulating these pathways for cancer treatment.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways
Abnormal Proliferation

